Linezolid in the treatment of subjects with complicated skin and soft tissue infections proven to be due to methicillin-resistant Staphylococcus aureus
Phase of Trial: Phase IV
Latest Information Update: 23 Mar 2015
At a glance
- Drugs Linezolid; Linezolid; Vancomycin
- Indications Methicillin-resistant Staphylococcus aureus infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Pfizer
- 07 Aug 2012 Actual patient number changed from 1052 to 1077 as reported by ClinicalTrials.gov record.
- 12 Sep 2009 Results of a post hoc analysis were presented at ICAAC 2009.
- 17 Dec 2008 Results were reported at ICAAC/IDSA 2008.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History